Clinical trial
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
NCT06334133
Study timeline
Study start (actual)2024-06-14Date precision: day
Registry last updated2026-07-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 1unresolved
Interventions
Sponsors & collaborators
vTv Therapeuticslead sponsor
Mapped research locations
San DiegoCalifornia, United States2Las VegasNevada, United States2SpokaneWashington, United States2BostonMassachusetts, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1AtlantaGeorgia, United States1San AntonioTexas, United States1SeattleWashington, United States1IndianapolisIndiana, United States1AustinTexas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06334133 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.